摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(1,2,3,6-Tetrahydropyridin-4-yl)pyrazine | 1075742-26-5

中文名称
——
中文别名
——
英文名称
2-(1,2,3,6-Tetrahydropyridin-4-yl)pyrazine
英文别名
——
2-(1,2,3,6-Tetrahydropyridin-4-yl)pyrazine化学式
CAS
1075742-26-5
化学式
C9H11N3
mdl
——
分子量
161.206
InChiKey
XUIRHKCTPDRCEQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.4
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    37.8
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-(1,2,3,6-Tetrahydropyridin-4-yl)pyrazine 、 Ethyl 2-ethoxy-3-[4-(2-methylsulfonyloxyethoxy)phenyl]propanoate 在 potassium carbonate 、 sodium iodide 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成
    参考文献:
    名称:
    Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARα/γ dual agonists
    摘要:
    Aryl-tetrahydropyridine derivatives were prepared and their PPAR alpha/gamma dual agonistic activities were evaluated. Among them, compound (S)-5b was identified as a potent PPAR alpha/gamma dual agonist with an EC50 of 1.73 and 0.64 mu M in hPPAR alpha and gamma, respectively. In diabetic (db/db) mice, compound (S)-5b showed good glucose lowering efficacy and favorable pharmacokinetic properties. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.08.020
  • 作为产物:
    描述:
    tert-butyl 4-pyrazin-2-yl-3,6-dihydro-2H-pyridine-1-carboxylate 在 三氟乙酸 作用下, 以 二氯甲烷 为溶剂, 生成 2-(1,2,3,6-Tetrahydropyridin-4-yl)pyrazine
    参考文献:
    名称:
    Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARα/γ dual agonists
    摘要:
    Aryl-tetrahydropyridine derivatives were prepared and their PPAR alpha/gamma dual agonistic activities were evaluated. Among them, compound (S)-5b was identified as a potent PPAR alpha/gamma dual agonist with an EC50 of 1.73 and 0.64 mu M in hPPAR alpha and gamma, respectively. In diabetic (db/db) mice, compound (S)-5b showed good glucose lowering efficacy and favorable pharmacokinetic properties. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.08.020
点击查看最新优质反应信息

文献信息

  • Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARα/γ dual agonists
    作者:Eunkyung Kim、Chan Sun Park、Taedong Han、Myung-Ho Bae、Wonee Chong、Choong Hyun Lee、Young Ah Shin、Byung-Nak Ahn、Mi Kyung Kim、Chang Yell Shin、Moon Ho Son、Jin Kwan Kim、Ho Sang Moon、Hyun Joo Shim、Eun Jung Kim、Soon Hoe Kim、Joong In Lim、Chun Ho Lee
    DOI:10.1016/j.bmcl.2008.08.020
    日期:2008.9
    Aryl-tetrahydropyridine derivatives were prepared and their PPAR alpha/gamma dual agonistic activities were evaluated. Among them, compound (S)-5b was identified as a potent PPAR alpha/gamma dual agonist with an EC50 of 1.73 and 0.64 mu M in hPPAR alpha and gamma, respectively. In diabetic (db/db) mice, compound (S)-5b showed good glucose lowering efficacy and favorable pharmacokinetic properties. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多